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A UPLC-MS/MS assay for the quantification of meropenem and piperacillin 
concentrations in human plasma. 
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Background: Meropenem and piperacillin are beta-lactam antibiotics that are widely used to 
treat severe infections in the intensive care unit. Various chromatographic methods with UV 
detection have been were developed to measure total plasma concentrations of these 
antibiotics. The objective of this work was to develop a rapid method for the simultaneous 
detection of these drugs in human plasma.  
Materials and Methods: After blood collection in lithium heparin tubes, samples were quickly 
centrifuged and plasma was frozen at -20°C until analysis. Plasma samples were spiked with 
oxacillin as an internal standard and deproteinised using acetonitrile. The supernatant was 
analysed using ultraperformance-liquid chromatography tandem mass spectrometry (UPLC-
MS/MS). The compounds were chromatographically separated on a Waters Acquity UPLC 
system with a BEH C18 column (1.7 µm, 100 mm × 2.1 mm) kept at 50°C and a gradient 
elution of water and acetonitrile, both containing 0.1% formic acid. Compounds were detected 
with a Waters Acquity TQD mass spectrometer operating in positive electrospray ionisation 
using a compound-specific MRM method. Total run time was 4 minutes.  
Results: The method was validated for precision and accuracy. Linearity was established up to 
a concentration of 80 mg/L (meropenem) and 200 mg/L (piperacillin). The validated method 
was used to evaluate the bench-top and refrigerator stability of meropenem and piperacillin 
levels in non-stabilised plasma samples. At room temperature, the stability was checked after 
1 hour and 24 hours and showed for both antibiotics a recovery of >95% and 60-65%, 
respectively. Storage of the plasma sample for 1 hour at room temperature, followed by 
storage at 4°C for 7 and 23 hours showed a decrease in drug concentration up to 15-20 %. 
Conclusion: Our method allows a rapid and simple determination of meropenem and 
piperacillin plasma concentrations in a single run. Application of this method in routine 
monitoring of meropenem and piperacillin for the intensive care unit is feasible, but requires a 
strict control of the pre-analytical phase. 
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